|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Baylor College of Medicine |
|---|---|
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00828633 |
Purpose
RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment.
PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.
| Condition | Intervention |
|---|---|
|
Prostate Cancer |
Other: internet-based intervention Other: survey administration Procedure: psychosocial assessment and care Procedure: quality-of-life assessment |
| Study Type: | Observational |
| Official Title: | PATIENT-REPORTED OUTCOMES FOR GAY MEN WITH LOCALIZED PROSTATE CANCER |
| Estimated Enrollment: | 200 |
| Study Start Date: | August 2008 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Patients complete a web-based survey about their disease (biopsy Gleason score, PSA at diagnosis, and T-stage), treatment (treatment type, time since treatment, and use of healthcare services [e.g., oral medications for erectile dysfunction]), symptom distress, and psychosocial factors (ethnicity, health literacy, level of social support, communication with provider, relationship status, and communication with partner) that affect their health-related quality of life. The data will be used to provide the information necessary to tailor an existing prostate cancer survivorship intervention to address the specific needs of gay men with prostate cancer.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Diagnosis of localized prostate cancer
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, Arizona | |
| Arizona State University - West Campus | Recruiting |
| Phoenix, Arizona, United States, 85069 | |
| Contact: David Coon, PhD 602-543-6064 david.w.coon@asu.edu | |
| United States, Texas | |
| Dan L. Duncan Cancer Center at Baylor College of Medicine | Recruiting |
| Houston, Texas, United States, 77030 | |
| Contact: Clinical Trials Office - Dan L. Duncan Cancer Center at Baylor 713-798-1297 | |
| Veterans Affairs Medical Center - Houston | Recruiting |
| Houston, Texas, United States, 77030 | |
| Contact: David M. Latini, PhD 713-794-8546 | |
| Canada, Ontario | |
| Ryerson University | Recruiting |
| Toronto, Ontario, Canada, M5B 2K3 | |
| Contact: Stacey Hart 416-979-5000, ext. 4247 Stacey.hart@psych.ryerson.ca | |
| Principal Investigator: | David M. Latini, PhD | Baylor College of Medicine |
More Information
| Responsible Party: | Dan L. Duncan Cancer Center at Baylor College of Medicine ( David M. Latini ) |
| Study ID Numbers: | CDR0000600597, BCM-H-21892 |
| Study First Received: | January 23, 2009 |
| Last Updated: | July 8, 2009 |
| ClinicalTrials.gov Identifier: | NCT00828633 History of Changes |
| Health Authority: | Unspecified |
|
stage I prostate cancer stage II prostate cancer |
|
Neoplasms Neoplasms by Site Prostatic Diseases Genital Neoplasms, Male |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |